Phosphodiesterase-5 inhibitors not tied to alzheimer disease risk
Phosphodiesterase-5 (PDE5) inhibitors seem not to be associated with a reduced risk for Alzheimer disease and related dementia, according to a study published online Oct. 4 in Brain Communications.
Oct 19, 2022
0
0